Journal
CLINICA CHIMICA ACTA
Volume 406, Issue 1-2, Pages 18-22Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.cca.2009.04.013
Keywords
Anti-PSA-mAb; Fluorescence; Immunochromatographic assay; Prostate specific antigen; Point-of-care-testing
Categories
Funding
- National Research Foundation of Korea [핵06B3111] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
Ask authors/readers for more resources
Background: Prostate specific antigen (PSA) is widely used as a clinical marker for diagnosis, screening, and prognosis of prostate cancer. A fluorescence (FL) dye-incorporated immunochromatographic assay (ICA) was developed for detection of PSA concentration in whole blood or serum. Methods: Whole blood or serum mixed with FL-conjugated detector was loaded onto a cartridge and incubated for 12 min. The FL intensity of the cartridge was then measured in a laser FL scanner. The analytical performance of the FL-ICA system was evaluated by precision and recovery tests. The comparability of the new method was examined with an automated analyzer. Results: A reliable correlation between area ratio (A(T)/A(C)), reflecting FL intensity of test/control line, and PSA concentration was observed (r = 0.998). The CVs of intra- and inter-assay precision in a range of 2.5-8 mu g/l were <6.0% and 4.5%, respectively, and analytical recovery of the FL-ICA system fell within 6.5% at the tested samples. When the FL-ICA method was compared with Abbott AxSYM and Bayer Centaur analyzers, there were strong correlations (r = 0.993 and r = 0.992, p < 0.0001). Conclusion: The FL-ICA system with point-of-care-testing (POCT) appeared to be an easy, fast and suitable method for measurement of PSA concentration in whole blood, and needs no accessory equipment to separate serum. (C) 2009 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available